Heyholder
‹ Activism Filings

DongBang Medical Co., Ltd. Q3 profit from the main business KRW 5.4 billion, up 33.7% from a year earlier

DongBang Medical Co., Ltd.· Periodic Report

AI summary · Not investment advice

In Q3, the company sold KRW 29.3 billion worth and earned KRW 5.4 billion from its main business, up 33.7% from a year earlier and down 14.5% from the prior quarter.

Operating profit · 3 months

KRW 5.4 billion

Key facts

Revenue (3 months)
KRW 29.3 billion
Net income (3 months)
KRW 2.5 billion
Period
Q3 (cumulative Jan 1, 2026 ~ Sep 30, 2026)
Revenue (prior-year 3 months)
KRW 30.0 billion
Revenue (year to date)
KRW 94.6 billion
Operating profit (prior-year 3 months)
KRW 4.1 billion
Operating profit (year to date)
KRW 17.8 billion
Net income (prior-year 3 months)
KRW 2.8 billion
Net income (year to date)
KRW 11.8 billion

Commentary

AI commentary · Not investment advice

What happened

Dongbang Medical filed its quarterly report for the third quarter on a consolidated basis. Sales for the latest 3 months were KRW 29.27 billion. That is 2.4% lower than a year earlier and 13.8% lower than the previous quarter.

In the company's terms

Operating profit (profit from the core business) for the 3 months was KRW 5.43 billion. That is 33.7% higher than a year earlier and 14.5% lower than the previous quarter.

What changes for shareholders

Net income (final profit after taxes and other costs) for the 3 months was KRW 2.48 billion. That is 12.8% lower than a year earlier and 37.8% lower than the previous quarter.

For the year to date, from January 1 to September 30, sales were KRW 94.61 billion. Operating profit was KRW 17.84 billion. Net income was KRW 11.75 billion.

Comments

No comments yet

Comments from shareholders will appear here.